Medical treatment to reduce total ischemic burden: Total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine-Reference-Cited by-同舟云学术

Medical treatment to reduce total ischemic burden: Total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine

Published:1995-01 Issue:1 Volume:25 Page:231-238
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

von Arnim Thomas

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: Clinical and prognostic significance;Bolognese;J Am Coll Cardiol,1992

2. Characterization and long-term prognosis of patients with effort-induced silent myocardial ischemia;Romeo;Eur Heart J,1992

3. Cardiac events in patients with silent myocardial ischemia;Kishida;Jpn Heart J,1992

4. Frequency and prognostic significance of silent coronary artery disease in patients with cerebral ischemia undergoing carotid endarterectomy;Urbinati;Am J Cardiol,1992

5. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease;Yeung;Circulation,1991

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of optimized resveratrol/piperine-loaded phytosomal nanocomplex for isoproterenol-induced myocardial infarction treatment;Journal of Liposome Research;2024-07-12

2. Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study;Advances in Therapy;2023-04-08

3. (Why to use fixed dose perindopril, bisoprolol combination in hypertonics with CHD?);Cor et Vasa;2023-03-01

4. Beta‑blockers after myocardial infarction and chronic coronary heart disease;Vnitřní lékařství;2022-04-26

5. The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases;Cardiovascular Drugs and Therapy;2021-09-17